New name, same ticker: enGene ties rebrand to a 2027 transition Biologics license filing for detalimogene is planned in 2H 2026. Why it matters: enGene says the rebrand reflects its commercial transition.

#ENGN #ENGNW enGene Announces Name Change to enGene Therapeutics Inc.

www.stocktitan.net/news/ENGN/en-gene-announ...

Fundamental analysis of $ENGNW (enGene Holdings Inc.) based on financial data and reported results.

#ENGNW #enGene